Key facts
- It has raised $1.8M; the latest was Later Stage VC in Sep 2025.
- Notable investors include San Nuo Technology, Zhongshan Torch Electronic Industry Fund Management, Zhuhai Sanying Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ZA Biomedical
- ·The full record, as it builds
Funding rounds
No funding rounds for ZA Biomedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ZA Biomedical
Manufacturer of innovative biopharmaceutical products intended for HPV-related diseases and various cancers. The company specailises in cancer therapeutic vaccines, topical peptide ointments for multidrug-resistant bacteria, treatments for genital warts and melanoma, and peptide-drug conjugates for advanced tumours, thereby improving patient outcomes in oncology and infectious disease care.
- Sector
- Healthcare
- HQ
- Zhongshan, China
- Founded
- 2018
- Employees
- 5
- Website
- wnlbiomed.com/
- Ownership
- Privately Held (backing)
ZA Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ZA Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ZA Biomedical in its N-PORT filings yet. We sweep new filings monthly.